Drug-Drug Interaction Prediction on DrugBank Dataset 2 57 (test)
51.61AccuracyCMF-ELN
Evaluation results
| Method | Links | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| CMF-ELNscenario=new drug–new drug, protocol=five-fold cross-validation, embedding size=128, learning rate=1e-32026.07 | 51.61 | 49.65 | 93.82 | 28.3 | 35.58 | 25.69 | 89 | — | 1.58 | |
| MDNNscenario=new drug–new drug, protocol=five-fold cross-validation2026.07 | 51.1 | 45.98 | 90.49 | 27.89 | 29.23 | 26.62 | 11 | 0.0047 | 6.17 | |
| MDF-SA-DDIscenario=new drug–new drug, protocol=five-fold cross-validation2026.07 | 51.05 | 49.26 | 93.61 | 26.09 | 31.24 | 23.72 | 11 | 0.006 | 4.04 | |
| MDDI-SCLscenario=new drug–new drug, protocol=five-fold cross-validation2026.07 | 50.08 | 47.87 | 94.06 | 27.52 | 31.28 | 24.83 | 11 | 0.0029 | 3.67 | |
| ImageDDIscenario=new drug–new drug, protocol=five-fold cross-validation2026.07 | 49.25 | 46.33 | 92.33 | 27.74 | 30.31 | 26.61 | 11 | 0.0037 | 5.25 | |
| Emer-GNNscenario=new drug–new drug, protocol=five-fold cross-validation2026.07 | 46.74 | 41.34 | 93.76 | 23.11 | 31.01 | 20.98 | 11 | 0.0037 | 4.75 | |
| MeT-DDIscenario=new drug–new drug, protocol=five-fold cross-validation2026.07 | 44.71 | 41.18 | 93.55 | 27.22 | 30.73 | 28.71 | 11 | 0.006 | 5.25 | |
| Know-DDIscenario=new drug–new drug, protocol=five-fold cross-validation2026.07 | 44.21 | 41.98 | 93.27 | 22.03 | 30.23 | 21.59 | 11 | 0.0028 | 5.58 | |
| MKG-FENNscenario=new drug–new drug, protocol=five-fold cross-validation2026.07 | 41.43 | 37.22 | 91.89 | 19.26 | 22.31 | 18.68 | 12 | 0.0022 | 8.92 |